Induct As · OSL:INDCT

Induct As — Investor Presentation (June 2026)

15 slides from Induct As's investor presentation, Jun 19, 2026

  1. Slide 1: Company presentation

    Induct AS 19 June 2026 Company presentation

  2. Slide 2: Disclaimer

    Disclaimer ABOUT THIS PRESENTATION By reading this company presentation (the "Presentation") or attending any meeting or oral presentation held in relation thereto, you (the "Recipient") agree to be bound by the following terms, conditions and limitations. The Presentation has been produced by Induc

  3. Slide 3: Disclaimer

    Disclaimer GOVERNING LAW AND JURISDICTION This Presentation and any dispute arising out of or in connection with this Presentation shall be governed by and construed in accordance with Norwegian law, and any such dispute shall be subject to the exclusive jurisdiction of the Norwegian courts. FORWARD

  4. Slide 4: Our vision

    OUR VISION To become the global operating system for care pathways , helping healthcare systems deliver better outcomes through connected workflows, clinical intelligence and data - driven care.

  5. Slide 5: Investment highlight

    Investment highlight 1 2 3 4 Established SaaS Proven technology Validated care pathway Positioned for the next foundation ready to scale module growth phase Stable recurring revenue from Highly scalable care pathway Deployed in NHS England for Focused organisation with a stand-alone products technol

  6. Slide 6: Core products and Commercial models

    Core products and Commercial models Care pathways Grant finders Innovation management Structured and streamlined treatment Our grant portals make it easier to find Our innovation solutions help workflows, ensuring faster, more funding opportunities for municipalities organisations turn ideas into me

  7. Slide 7: Care Pathways

    Care Pathways CHALLENGES > Monolithic EHR systems with generic usability and costly upgrades > Need for multi-disciplinary care models for an ageing population with comorbidities > Pressure to deliver better patient outcomes while managing limited resources > AI-driven healthcare to cover workforce

  8. Slide 8: Care Pathways

    Care Pathways MARKET POTENTIAL Care pathways sit within the fast-growing care management and healthcare SaaS market. The narrow pathway opportunity is already a multi-billion-dollar market, while the broader care orchestration category is estimated at ~$17B today and projected to exceed ~$60B within

  9. Slide 9: Care Pathways

    Care Pathways 1 2 3 One hospital, one pathway Several hospitals, one pathway One hospital, several pathways Hospital patient group Patient participation Care pathway + pathway record Data reporting Treatment plans Master patient record Home care feedback Clinical dialogue Standardised workflow Best-

  10. Slide 10: Clinical Validation

    200.000 patients in the UK have the Clinical Validation life-threatening severe asthma diagnosis “Induct will radically improve how clinical teams care for patients with severe asthma in Portsmouth – better data NOK 14,7 bln quality, referrals, and faster access to information for Conservative estim

  11. Slide 11: Grant platforms and innovation management

    Grant platforms and innovation management – existing ARR supporting future initiatives Grant platforms (Tilskuddsportaler) Innovation management - Proven SaaS platform for securing funding opportunities - SaaS solution for turning ideas into measurable results Thousands of funding opportunities are

  12. Slide 12: Care Pathways year plan and milestone estimates

    Care Pathways 3 YEAR PLAN – securing a solid market position MILESTONE ESTIMATES Care Pathways H2 2026 • Vertical market dominance within respiratory diseases in > ARR subscription - Portsmouth the UK. > RTP* funding secured • Starting with the roll-out of the Severe Asthma pathway > New severe asth

  13. Slide 13: Growth & Use of Proceeds

    Growth & Use of Proceeds GROWTH ESTIMATES USE OF PROSEEDS The company targets strong revenue growth in the coming The company will invest in the following areas in the short years, with revenues expected to approximately double in term: both 2027 and 2028. > Sales and marketing > Product management

  14. Slide 14: Organisation

    Organisation Chief Executive Officer Synnøve Jacobsen Chief Product Officer Chief Sales and Marketing Officer Chief Technology Officer Chief Financial Officer (interim) tbd tbd Ignacio Orteu Eli Cathrine Disch Customer Success Product Manager Health Sales & KA Health Scrum Master Accounting Manager

  15. Slide 15: Induct AS

    Induct AS www.induct.net ‘Lncuct

Induct AS — Investor Presentation (June 2026) on 6ix